Welcome to the investors section of Adocia

Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.

Adocia Corporate presentation – January 2020 de adocia

Latest Press Releases

2020/07/03Half year report on Adocia’s liquidity agreement with Kepler Capital Markets
2020/06/05Number of shares and voting rights of ADOCIA as of May 31, 2020

All Press releases

Next events

September 8-11, 2020 Francophone Diabetes Society Congress, Brussels, Belgium - This annual event brings together all members of the French-speaking medical and paramedical community, invested daily in the vast fields of clinical and / or basic diabetology. At this occasion, Adocia will be presenting M1 Pram (ADO09).

All events

ADOCIA uses cookies for the effective operation of the Site and to monitor and analyze the traffic on the Site.
The information collected through cookies is solely and strictly for ADOCIA, in compliance with the regulation applicable to the protection of personal data. They are never transmitted to third-parties.

Financial

Welcome to the investors section of Adocia

The INPI France patent list filed 2019 ranks Adocia in 4th place among French SMEs

ADA2020: read Adocia Poster M1Pram on line